Sirnaomics to Present at 2019 BIO CEO & Investor Conference


Sirnaomics, Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, today announced that the management will present and conduct face-to-face meetings at the 2019 BIO CEO & Investor Conference, to be held in New York, NY on February 11-12.


Patrick Y. Lu, PhD., Founder and CEO of Sirnaomics, is scheduled to present on Monday, February 11 at 11:15 a.m. Eastern Time. Dr. Lu will share an overview of the Company’s differentiated RNAi technology platform that leverages proprietary polypeptide nanoparticle (PNP) drug delivery system, as well as robust clinical pipeline of RNAi therapeutics spanning oncology and anti-fibrosis indications.